This article delves into the critical need for reform in public spending...
Fundamentals for Max Healthcare Institute Limited
Last Updated:
2025-10-16 19:43
Overall Fundamental outlook
Business Operations:
Sector: Healthcare Industry: Medical Care Facilities
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Revenue projections:
Revenue projections for MAXHEALTH Revenues for Max Healthcare Institute Limited are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.
Financial Ratios:
currentRatio
0.87800
forwardPE
53.30509
debtToEquity
32.09000
earningsGrowth
0.26600
revenueGrowth
0.34200
grossMargins
0.62281
operatingMargins
0.23514
trailingEps
10.96000
forwardEps
0.00000
Max Healthcare Institute Limited's forward PE being elevated could limit price appreciation and heighten the risk of a correction. Investors need to carefully assess this parameter in combination with other fundamentals to determine whether the stock is overvalued. MAXHEALTH's positive earnings and revenue growth signal that the company is expected to expand its business. The company's increasing profits and sales reflect strong financial health, suggesting continued growth and success in the coming periods. MAXHEALTH's positive gross and operating margins indicate that the company is performing profitably. These margins reflect efficient cost control and revenue generation, signaling a strong financial foundation for continued success.
Price projections:
Price projections for MAXHEALTH MAXHEALTH's price projections have gradually risen, indicating growing confidence in the company's prospects. This upward trend suggests that analysts expect MAXHEALTH to continue performing well in the future.
Recommendation changes over time:
Recommendations trend for MAXHEALTH
Analysts have maintained a buy bias for MAXHEALTH, which could prompt investors to consider the stock as a viable investment. With this positive outlook, MAXHEALTH is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth look at the UK’s Q2 2025 GDP release by ONS,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.